Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy

JAAD Case Rep. 2024 Nov 19:56:51-53. doi: 10.1016/j.jdcr.2024.09.029. eCollection 2025 Feb.

Authors

Jennifer Strong¹, Vincent I Poon², Patrick Hallaert¹, Deneise Francis³, Danielle M Pastor², Leslie Castelo-Soccio¹, Julius Strauss², Isaac Brownell^{1

2}

Affiliations

¹ Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.
² Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
³ Office of Research Nursing, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.

No abstract available

Keywords: alopecia areata; checkpoint inhibitors; hair repigmentation; immune-related adverse event; immunotherapy.

Publication types

Case Reports